To further confirm the intracellular delivery mediated by GLUT-1, the cancer cells were firstly exposed to phloretin to block GLUT-1 and then exposed to the polymeric nanocarriers before evaluating their cellular uptake by CLSM and FCM (62, 64). This evidence concerns the gene SLC2A1 and cancer.